Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Extrapyramidal side effects: a historical perspective.

The Journal of Clinical Psychiatry

|September 1, 1987

Summary

This summary is machine-generated.

Neuroleptic drugs can cause Parkinsonism-like symptoms, known as extrapyramidal side effects. These adverse reactions are not linked to antipsychotic effects but impact patient treatment acceptance and social adjustment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Is it denial or wisdom to accept life threatening illness?

BMJ (Clinical research ed.)·2001

Same author

Lithium discontinuation during pregnancy.

The American journal of psychiatry·2001

Same author

Comparing psychotherapy and pharmacotherapy.

The American journal of psychiatry·2001

Same author

Olanzapine and negative and positive symptoms.

The American journal of psychiatry·2001

Same author

Mass psychogenic illness attributed to toxic exposure at a high school.

The New England journal of medicine·2000

Same author

Comparison of bifrontal and bitemporal ECT for major depression.

The American journal of psychiatry·2000

Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026

Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026

Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026

Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026

Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026

Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026

See all related articles

Area of Science:

Neuroscience
Psychopharmacology
Medical History

Background:

Neuroleptic agents, introduced in 1952, are used for treating psychosis.
Early observations noted Parkinsonism-like symptoms associated with chlorpromazine.
The relationship between these symptoms and antipsychotic efficacy was initially unclear.

Observation:

Chlorpromazine, a key neuroleptic, induced extrapyramidal side effects shortly after its 1952 introduction.
These symptoms were initially misattributed to the antipsychotic action of neuroleptics.
Further research distinguished extrapyramidal side effects from antipsychotic activity.

Findings:

Extrapyramidal side effects are a distinct class of adverse reactions to neuroleptic agents.
These side effects are not directly correlated with the therapeutic antipsychotic effects.

Related Experiment Videos

The occurrence of extrapyramidal side effects significantly influences patient drug acceptance.

Implications:

Understanding extrapyramidal side effects is crucial for effective neuroleptic therapy.
Minimizing these adverse reactions can improve patient adherence and social functioning.
Historical research highlights the evolving understanding of neuroleptic drug safety profiles.